Get started
Work

Supplementary Fig S1 from Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma

Year: 2023
Type: supplementary-materials
Abstract: Effects of ADXS31-164 on hematological parameters at 24 hours post infusion.
DOI: 10.1158/1078-0432.22465185.v1
Authors: Nicola J. Mason, Josephine S. Gnanandarajah, Julie B. Engiles, Falon Gray, Danielle Laughlin, Anita Gaurnier-Hausser, Anu Wallecha, Margie Huebner, Yvonne Paterson
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4361926288
Cites:
Cited by:
Related to: 10